These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
217 related items for PubMed ID: 9607866
1. Vaccination with a Haemophilus influenzae type b conjugate vaccine reduces oropharyngeal carriage of H. influenzae type b among Gambian children. Adegbola RA, Mulholland EK, Secka O, Jaffar S, Greenwood BM. J Infect Dis; 1998 Jun; 177(6):1758-61. PubMed ID: 9607866 [Abstract] [Full Text] [Related]
2. Immunogenicity and safety of four different doses of Haemophilus influenzae type b-tetanus toxoid conjugated vaccine, combined with diphtheria-tetanus-pertussis vaccine (DTP-Hib), in Indonesian infants. Punjabi NH, Richie EL, Simanjuntak CH, Harjanto SJ, Wangsasaputra F, Arjoso S, Rofiq A, Prijanto M, Julitasari, Yela U, Herzog C, Cryz SJ. Vaccine; 2006 Mar 10; 24(11):1776-85. PubMed ID: 16303216 [Abstract] [Full Text] [Related]
7. Antibody response to Haemophilus influenzae type b tetanus conjugate vaccine with two doses given at 3 and 5 months of age. Guimarães T, Cereda RF, Bianchin PJ, Nagao AT, Sampaio MC, Mendonça JS. Int J Infect Dis; 2002 Jun 26; 6(2):113-7. PubMed ID: 12121598 [Abstract] [Full Text] [Related]
9. Safety and immunogenicity of two Haemophilus influenzae type b polysaccharide-tetanus toxoid conjugate vaccines (PRP-T) given with diphtheria-tetanus-pertussis vaccine to young Papua New Guinean children. Lehmann D, Kakazo M, Saleu G, Taime J, Javati A, Namuigi P, Alpers MP, Wegmüller B, Zellmeyer M, Fürer E, Que JU, Herzog C. P N G Med J; 2001 Jun 26; 44(1-2):6-16. PubMed ID: 12418673 [Abstract] [Full Text] [Related]
13. Economisation of vaccination against Haemophilus influenzae type b: a randomised trial of immunogenicity of fractional-dose and two-dose regimens. Lagos R, Valenzuela MT, Levine OS, Losonsky GA, Erazo A, Wasserman SS, Levine MM. Lancet; 1998 May 16; 351(9114):1472-6. PubMed ID: 9605803 [Abstract] [Full Text] [Related]
15. Antigenuria in Gambian infants following immunization with a Haemophilus influenzae type b polyribosylribitol phosphate-tetanus toxoid protein conjugate (PRP-T) vaccine. Adegbola RA, Leach A, Mulholland K, Hilton S, Demba E, Jaffar S, Greenwood BM. Diagn Microbiol Infect Dis; 1998 Sep 16; 32(1):15-9. PubMed ID: 9791752 [Abstract] [Full Text] [Related]
16. Large scale, postlicensure, selective vaccination of Chilean infants with PRP-T conjugate vaccine: practicality and effectiveness in preventing invasive Haemophilus influenzae type b infections. Lagos R, Horwitz I, Toro J, San Martin O, Abrego P, Bustamante C, Wasserman SS, Levine OS, Levine MM. Pediatr Infect Dis J; 1996 Mar 16; 15(3):216-22. PubMed ID: 8852909 [Abstract] [Full Text] [Related]
17. Primary and booster immunization with a diphtheria, tetanus, acellular pertussis, hepatitis B (DTPa-HBV) and Haemophilus influenzae type b (Hib) vaccine administered separately or together is safe and immunogenic. Marshall H, McIntyre P, Roberton D, Dinan L, Hardt K. Int J Infect Dis; 2010 Jan 16; 14(1):e41-9. PubMed ID: 19467896 [Abstract] [Full Text] [Related]
18. A combined Haemophilus influenzae type B Neisseria meningitidis serogroup C tetanus toxoid conjugate vaccine is immunogenic and well-tolerated when coadministered with diphtheria, tetanus, acellular pertussis hepatitis B-inactivated poliovirus at 3, 5 and 11 months of age: results of an open, randomized, controlled study. Vesikari T, Forstén A, Desole MG, Ferrera G, Caubet M, Mesaros N, Boutriau D. Pediatr Infect Dis J; 2013 May 16; 32(5):521-9. PubMed ID: 23190785 [Abstract] [Full Text] [Related]